MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 72 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $8,000 | -20.0% | 10,000 | 0.0% | 0.00% | +33.3% |
Q4 2021 | $10,000 | -23.1% | 10,000 | 0.0% | 0.00% | -57.1% |
Q3 2021 | $13,000 | +62.5% | 10,000 | 0.0% | 0.01% | +250.0% |
Q2 2021 | $8,000 | -27.3% | 10,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $11,000 | -21.4% | 10,000 | 0.0% | 0.00% | -33.3% |
Q4 2020 | $14,000 | +75.0% | 10,000 | 0.0% | 0.00% | -25.0% |
Q3 2020 | $8,000 | 0.0% | 10,000 | 0.0% | 0.00% | +33.3% |
Q2 2020 | $8,000 | +33.3% | 10,000 | 0.0% | 0.00% | -40.0% |
Q1 2020 | $6,000 | -73.9% | 10,000 | 0.0% | 0.01% | +25.0% |
Q4 2019 | $23,000 | +283.3% | 10,000 | 0.0% | 0.00% | – |
Q3 2019 | $6,000 | -33.3% | 10,000 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $9,000 | -59.1% | 10,000 | -50.0% | 0.00% | -50.0% |
Q1 2019 | $22,000 | +266.7% | 20,000 | +100.0% | 0.00% | -33.3% |
Q4 2018 | $6,000 | -33.3% | 10,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $9,000 | +125.0% | 10,000 | 0.0% | 0.00% | +200.0% |
Q2 2018 | $4,000 | -50.0% | 10,000 | 0.0% | 0.00% | -50.0% |
Q1 2018 | $8,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 10,188,312 | $11,105,000 | 1.28% |
Stonepine Capital Management, LLC | 2,008,006 | $2,189,000 | 1.26% |
CVI Holdings, LLC | 909,625 | $991,000 | 0.94% |
Vivo Capital, LLC | 6,818,181 | $7,432,000 | 0.74% |
Broadfin Capital, LLC | 2,727,272 | $2,973,000 | 0.61% |
Telemetry Investments, L.L.C. | 650,000 | $708,000 | 0.36% |
Granite Point Capital Management, L.P. | 1,706,134 | $1,860,000 | 0.18% |
J. Goldman & Co LP | 1,045,000 | $1,139,000 | 0.06% |
Tibra Equities Europe Ltd | 241,966 | $264,000 | 0.03% |
IPG Investment Advisors LLC | 42,500 | $46,325,000 | 0.02% |